v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development (including related party purchases of $243 and $547 for the three months ended September 30, 2022 and 2021, respectively, $1,470 and $1,523 for the nine months ended September 30, 2022 and 2021, respectively.) $ 73,870 $ 52,092 $ 220,146 $ 140,310
Selling, general and administrative (including related party purchases of $46 and $154 for the three months ended September 30, 2022 and 2021, respectively, $335 and $390 for the nine months ended September 30, 2022 and 2021, respectively.) 23,251 15,607 70,700 41,587
Total operating expenses 97,121 67,699 290,846 181,897
Loss from operations (97,121) (67,699) (290,846) (181,897)
Interest and other income, net 5,395 163 8,766 872
Interest expense (35) (484) (95) (2,388)
Income from equity method investment 0 10,331 19,039 19,222
Transaction expenses related to merger 0 (9,015) 0 (9,015)
Gain (Loss) from change in fair value of warrants and earnout shares 12,560 (11,489) 72,072 (11,489)
Convertible notes extinguishment loss 0 (665) 0 (665)
Total other income (loss), net 17,920 (11,159) 99,782 (3,463)
Loss before income taxes (79,201) (78,858) (191,064) (185,360)
Income tax expense 5 0 35 9
Net loss $ (79,206) $ (78,858) $ (191,099) $ (185,369)
Net loss per share, basic (in dollars per share) $ (0.14) $ (0.20) $ (0.33) $ (0.91)
Net loss per share, diluted (in dollars per share) $ (0.14) $ (0.20) $ (0.33) $ (0.91)
Weighted average number of shares outstanding, basic (in shares) 583,970,409 385,560,732 581,458,391 203,536,351
Weighted average number of shares outstanding, diluted (in shares) 583,970,409 385,560,732 581,458,391 203,536,351

Source